台湾皮肤科协会特应性皮炎管理共识：2020年更新

2020-05-22 台湾皮肤科医学会 J Formos Med Assoc . 2020 Jun 18;S0929-6646(20)30237-0.

特应性皮炎(AD)是一种慢性炎症性疾病，常见于儿童，成人也越来越多地被认识。随着AD治疗发展的最新进展，台湾皮肤科协会(TDA)成立了一个委员会来更新台湾AD管理的共识。本报告介绍了2020年AD管理

中文标题：

发布机构：

台湾皮肤科医学会

发布日期：

2020-05-22

简要介绍：

特应性皮炎(AD)是一种慢性炎症性疾病，常见于儿童，成人也越来越多地被认识。随着AD治疗发展的最新进展，台湾皮肤科协会(TDA)成立了一个委员会来更新台湾AD管理的共识。本报告介绍了2020年AD管理的更新共识。

研究方法
由11名核心成员组成的小组在前两次会议期间召开了审查和讨论AD管理和建议草案的各个方面。2015年TDA共识和2017年欧洲指南，以及最近的同行评审文章，作为更新的基础。在第三次会议上，邀请在全国范围内选出的AD专家皮肤科医生对最终的发言进行投票。共有27位皮肤科专家参加了最终会议。当评分7-9分（总分9分）占总票数≥75%时，达成共识。

评议结果
对AD的治疗方案按治疗项目达成共识。提出了一个治疗算法，以说明每种模式在基础护理、急性疾病控制和维持治疗方面的地位。讨论了儿科人群以及妊娠期和哺乳期妇女的特殊注意事项。

结语
局部皮质类固醇与长期润肤剂治疗仍是AD治疗的基石。当局部治疗和光疗无法控制疾病时，系统治疗是适用的。最近批准的dupilumab和新兴的靶向疗法有望为现有方案不能充分控制疾病的患者带来显著的临床获益。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=88be91c00192a56c, title=台湾皮肤科协会特应性皮炎管理共识：2020年更新, enTitle=, guiderFrom=J Formos Med Assoc . 2020 Jun 18;S0929-6646(20)30237-0., authorId=0, author=, summary=特应性皮炎(AD)是一种慢性炎症性疾病，常见于儿童，成人也越来越多地被认识。随着AD治疗发展的最新进展，台湾皮肤科协会(TDA)成立了一个委员会来更新台湾AD管理的共识。本报告介绍了2020年AD管理, cover=, journalId=0, articlesId=null, associationId=1416, associationName=台湾皮肤科医学会, associationIntro=, copyright=0, guiderPublishedTime=Fri May 22 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=特应性皮炎(AD)是一种慢性炎症性疾病，常见于儿童，成人也越来越多地被认识。随着AD治疗发展的最新进展，台湾皮肤科协会(TDA)成立了一个委员会来更新台湾AD管理的共识。本报告介绍了2020年AD管理的更新共识。 研究方法 由11名核心成员组成的小组在前两次会议期间召开了审查和讨论AD管理和建议草案的各个方面。2015年TDA共识和2017年欧洲指南，以及最近的同行评审文章，作为更新的基础。在第三次会议上，邀请在全国范围内选出的AD专家皮肤科医生对最终的发言进行投票。共有27位皮肤科专家参加了最终会议。当评分7-9分（总分9分）占总票数≥75%时，达成共识。 评议结果 对AD的治疗方案按治疗项目达成共识。提出了一个治疗算法，以说明每种模式在基础护理、急性疾病控制和维持治疗方面的地位。讨论了儿科人群以及妊娠期和哺乳期妇女的特殊注意事项。 结语 局部皮质类固醇与长期润肤剂治疗仍是AD治疗的基石。当局部治疗和光疗无法控制疾病时，系统治疗是适用的。最近批准的dupilumab和新兴的靶向疗法有望为现有方案不能充分控制疾病的患者带来显著的临床获益。, tagList=[TagDto(tagId=13273, tagName=特应性皮炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4098, appHits=224, showAppHits=0, pcHits=1058, showPcHits=3874, likes=1, shares=16, comments=25, approvalStatus=1, publishedTime=Tue Jun 23 17:24:04 CST 2020, publishedTimeString=2020-05-22, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Tue Jun 23 17:23:58 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 09:22:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=10.1200@JCO.20.00866.pdf)])

10.1200@JCO.20.00866.pdf

下载请点击：

评论区 (15)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2189937, encodeId=8d5e218993ef4, content=想要指南 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=461a8327442, createdName=ms2000001460297589, createdTime=Wed Feb 28 18:32:59 CST 2024, time=2024-02-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1198133, encodeId=7c331198133a3, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Mon Feb 28 20:12:04 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057084, encodeId=ecaa105e08465, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe2c2142955, createdName=1351ff470am, createdTime=Sun Oct 03 11:30:28 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013730, encodeId=8ca91013e3048, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e15592442, createdName=ms2000000045756516, createdTime=Thu Sep 02 11:46:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001615, encodeId=5936100161544, content=中国指南在哪里, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Thu Jul 22 10:26:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
2024-02-28 ms2000001460297589 来自安徽省

想要指南

8 1

展开1条回复
[GetPortalCommentsPageByObjectIdResponse(id=2189937, encodeId=8d5e218993ef4, content=想要指南 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=461a8327442, createdName=ms2000001460297589, createdTime=Wed Feb 28 18:32:59 CST 2024, time=2024-02-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1198133, encodeId=7c331198133a3, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Mon Feb 28 20:12:04 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057084, encodeId=ecaa105e08465, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe2c2142955, createdName=1351ff470am, createdTime=Sun Oct 03 11:30:28 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013730, encodeId=8ca91013e3048, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e15592442, createdName=ms2000000045756516, createdTime=Thu Sep 02 11:46:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001615, encodeId=5936100161544, content=中国指南在哪里, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Thu Jul 22 10:26:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
2022-02-28 ms3000001862313380

为了积分

44 0
[GetPortalCommentsPageByObjectIdResponse(id=2189937, encodeId=8d5e218993ef4, content=想要指南 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=461a8327442, createdName=ms2000001460297589, createdTime=Wed Feb 28 18:32:59 CST 2024, time=2024-02-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1198133, encodeId=7c331198133a3, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Mon Feb 28 20:12:04 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057084, encodeId=ecaa105e08465, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe2c2142955, createdName=1351ff470am, createdTime=Sun Oct 03 11:30:28 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013730, encodeId=8ca91013e3048, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e15592442, createdName=ms2000000045756516, createdTime=Thu Sep 02 11:46:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001615, encodeId=5936100161544, content=中国指南在哪里, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Thu Jul 22 10:26:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
2021-10-03 1351ff470am

学习了

65 0
[GetPortalCommentsPageByObjectIdResponse(id=2189937, encodeId=8d5e218993ef4, content=想要指南 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=461a8327442, createdName=ms2000001460297589, createdTime=Wed Feb 28 18:32:59 CST 2024, time=2024-02-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1198133, encodeId=7c331198133a3, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Mon Feb 28 20:12:04 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057084, encodeId=ecaa105e08465, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe2c2142955, createdName=1351ff470am, createdTime=Sun Oct 03 11:30:28 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013730, encodeId=8ca91013e3048, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e15592442, createdName=ms2000000045756516, createdTime=Thu Sep 02 11:46:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001615, encodeId=5936100161544, content=中国指南在哪里, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Thu Jul 22 10:26:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
2021-09-02 ms2000000045756516

哈哈哈

64 0
[GetPortalCommentsPageByObjectIdResponse(id=2189937, encodeId=8d5e218993ef4, content=想要指南 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=461a8327442, createdName=ms2000001460297589, createdTime=Wed Feb 28 18:32:59 CST 2024, time=2024-02-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1198133, encodeId=7c331198133a3, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Mon Feb 28 20:12:04 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057084, encodeId=ecaa105e08465, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe2c2142955, createdName=1351ff470am, createdTime=Sun Oct 03 11:30:28 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013730, encodeId=8ca91013e3048, content=哈哈哈, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7e15592442, createdName=ms2000000045756516, createdTime=Thu Sep 02 11:46:38 CST 2021, time=2021-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001615, encodeId=5936100161544, content=中国指南在哪里, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/10/956fcb05aa73cca69de364b71c5ffa46.jpg, createdBy=158c5136911, createdName=1466a102m75(暂无昵称), createdTime=Thu Jul 22 10:26:23 CST 2021, time=2021-07-22, status=1, ipAttribution=)]
2021-07-22 1466a102m75(暂无昵称)

中国指南在哪里

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

风湿免疫科指南

台湾皮肤科协会特应性皮炎管理共识：2020年更新

相关指南

科室

工具

服务